Skip to main content

Table 1 Clinical and pathological characteristics of adjuvant treated SEOC patient samples

From: Identification of the IGF1/PI3K/NF κB/ERK gene signalling networks associated with chemotherapy resistance and treatment response in high-grade serous epithelial ovarian cancer

Sample

Age

Stage

PFS (months)

Classification

1100

54

IIIc

5

Resistant

1101

55

IV

5

Resistant

1240

64

III

<3

Resistant

1299

53

IIIb

3

Resistant

1413

47

IV

<3

Resistant

1587

54

IIIc

0

Resistant

1605

51

IIb

3

Resistant

1703

48

IIIc

6

Resistant

1776

58

IIIc

6

Resistant

D00443

51

III

5

Resistant

1359

62

IIIc

8

Partially Resistant

1680

67

IIc

7

Partially Resistant

1157

61

IIIc

36

Sensitive

1188

58

III

34

Sensitive

1224

22

Sensitive

1296

61

II

39

Sensitive

1304

51

IIIa

26

Sensitive

1308

49

IIIc

25

Sensitive

1351

55

IV

No recurrence

Sensitive

1355

68

IIa

23

Sensitive

1381

51

IIIa

25

Sensitive

1561

63

IIb

25

Sensitive

1625

54

IIIb

26

Sensitive

1627

52

IIIa

No recurrence

Sensitive

1706

61

IIIa

No recurrence

Sensitive

B01183

79

IIIc

22

Sensitive

B01360

54

IIIc

19

Sensitive

B01440

53

IIIc

20

Sensitive